Changes in cMRI parameters following a switch to riociguat from phosphodiesterase type 5 inhibitors (PDE5i) in patients with pulmonary arterial hypertension: a REPLACE substudy

S. Rosenkranz, R. L. Benza,H. A. Ghofrani, E. Gruenig,M. M. Hoeper,A. Peacock,G. Simonneau,D. Vizza,C. Meier, K. Vogtlaender,A. Vonk-Noordegraaf

EUROPEAN HEART JOURNAL(2021)

引用 0|浏览8
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要